Figure 1

Overview of the clinical study design. There were 35 participants in probiotic and placebo groups totaling 70 participants. Fecal samples were taken at 4 time points for 16S rRNA gene amplicon sequencing and ABR microarray for a total of 280 DNA fecal samples that were analyzed.